INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME

Juan B. Yepez, Felipe A. Murati, Michele Pettito, J Fernando Arevalo

Research output: Contribution to journalArticle

Abstract

Purpose: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. Methods: Case report. Results: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. Conclusion: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.

Original languageEnglish (US)
Pages (from-to)236-239
Number of pages4
JournalRetinal Cases and Brief Reports
Volume11
Issue number3
DOIs
StatePublished - Jun 1 2017

Keywords

  • branch retinal artery occlusion
  • encephalopathy
  • hearing loss
  • intravitreal triamcinolone
  • Susac Syndrome

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME'. Together they form a unique fingerprint.

  • Cite this